Annual Operating Profit
$1.49 B
+$569.26 M+61.68%
December 31, 2023
Summary
- As of February 11, 2025, RPRX annual operating income is $1.49 billion, with the most recent change of +$569.26 million (+61.68%) on December 31, 2023.
- During the last 3 years, RPRX annual operating profit has fallen by -$168.30 million (-10.14%).
- RPRX annual operating profit is now -43.12% below its all-time high of $2.62 billion, reached on December 31, 2019.
Performance
RPRX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
$735.07 M
+$465.44 M+172.62%
September 30, 2024
Summary
- As of February 11, 2025, RPRX quarterly operating income is $735.07 million, with the most recent change of +$465.44 million (+172.62%) on September 30, 2024.
- Over the past year, RPRX quarterly operating profit has increased by +$808.85 million (+1096.39%).
- RPRX quarterly operating profit is now -44.81% below its all-time high of $1.33 billion, reached on December 31, 2019.
Performance
RPRX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
$1.54 B
+$583.63 M+60.78%
September 30, 2024
Summary
- As of February 11, 2025, RPRX TTM operating income is $1.54 billion, with the most recent change of +$583.63 million (+60.78%) on September 30, 2024.
- Over the past year, RPRX TTM operating profit has increased by +$604.42 million (+64.34%).
- RPRX TTM operating profit is now -41.42% below its all-time high of $2.64 billion, reached on June 30, 2020.
Performance
RPRX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
RPRX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +61.7% | +1096.4% | +64.3% |
| 3 y3 years | -10.1% | +1096.4% | +64.3% |
| 5 y5 years | +9.4% | +38.0% | -41.1% |
RPRX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +61.7% | at high | +1096.4% | at high | +67.3% |
| 5 y | 5-year | -43.1% | +61.7% | -44.8% | +1096.4% | -41.4% | +67.3% |
| alltime | all time | -43.1% | +61.7% | -44.8% | +1096.4% | -41.4% | +258.3% |
Royalty Pharma Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $735.07 M(+172.6%) | $1.54 B(+60.8%) |
| Jun 2024 | - | $269.63 M(-465.5%) | $960.19 M(+2.2%) |
| Mar 2024 | - | -$73.77 M(-112.0%) | $939.40 M(-37.0%) |
| Dec 2023 | $1.49 B(+61.7%) | $612.90 M(+304.7%) | $1.49 B(+47.4%) |
| Sep 2023 | - | $151.44 M(-39.1%) | $1.01 B(-3.9%) |
| Jun 2023 | - | $248.84 M(-48.0%) | $1.05 B(-10.9%) |
| Mar 2023 | - | $478.97 M(+259.7%) | $1.18 B(+28.1%) |
| Dec 2022 | $922.89 M(-35.5%) | $133.17 M(-30.7%) | $922.89 M(-2.1%) |
| Sep 2022 | - | $192.21 M(-49.1%) | $943.14 M(-10.5%) |
| Jun 2022 | - | $377.79 M(+71.9%) | $1.05 B(-25.8%) |
| Mar 2022 | - | $219.72 M(+43.2%) | $1.42 B(-0.7%) |
| Dec 2021 | $1.43 B | $153.42 M(-49.4%) | $1.43 B(-13.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $303.05 M(-59.3%) | $1.66 B(-11.1%) |
| Jun 2021 | - | $744.95 M(+224.9%) | $1.86 B(+22.0%) |
| Mar 2021 | - | $229.30 M(-39.5%) | $1.53 B(-8.0%) |
| Dec 2020 | $1.66 B(-36.7%) | $379.11 M(-25.7%) | $1.66 B(-36.5%) |
| Sep 2020 | - | $510.57 M(+24.7%) | $2.61 B(-0.8%) |
| Jun 2020 | - | $409.35 M(+13.3%) | $2.64 B(+3.2%) |
| Mar 2020 | - | $361.43 M(-72.9%) | $2.55 B(-2.6%) |
| Dec 2019 | $2.62 B(+92.3%) | $1.33 B(+150.1%) | $2.62 B(+103.1%) |
| Sep 2019 | - | $532.50 M(+62.4%) | $1.29 B(+70.2%) |
| Jun 2019 | - | $327.86 M(-23.9%) | $758.76 M(+76.1%) |
| Mar 2019 | - | $430.90 M | $430.90 M |
| Dec 2018 | $1.36 B(+45.2%) | - | - |
| Dec 2017 | $939.69 M | - | - |
FAQ
- What is Royalty Pharma annual operating income?
- What is the all time high annual operating profit for Royalty Pharma?
- What is Royalty Pharma annual operating profit year-on-year change?
- What is Royalty Pharma quarterly operating income?
- What is the all time high quarterly operating profit for Royalty Pharma?
- What is Royalty Pharma quarterly operating profit year-on-year change?
- What is Royalty Pharma TTM operating income?
- What is the all time high TTM operating profit for Royalty Pharma?
- What is Royalty Pharma TTM operating profit year-on-year change?
What is Royalty Pharma annual operating income?
The current annual operating profit of RPRX is $1.49 B
What is the all time high annual operating profit for Royalty Pharma?
Royalty Pharma all-time high annual operating income is $2.62 B
What is Royalty Pharma annual operating profit year-on-year change?
Over the past year, RPRX annual operating income has changed by +$569.26 M (+61.68%)
What is Royalty Pharma quarterly operating income?
The current quarterly operating profit of RPRX is $735.07 M
What is the all time high quarterly operating profit for Royalty Pharma?
Royalty Pharma all-time high quarterly operating income is $1.33 B
What is Royalty Pharma quarterly operating profit year-on-year change?
Over the past year, RPRX quarterly operating income has changed by +$808.85 M (+1096.39%)
What is Royalty Pharma TTM operating income?
The current TTM operating profit of RPRX is $1.54 B
What is the all time high TTM operating profit for Royalty Pharma?
Royalty Pharma all-time high TTM operating income is $2.64 B
What is Royalty Pharma TTM operating profit year-on-year change?
Over the past year, RPRX TTM operating income has changed by +$604.42 M (+64.34%)